Home Cart Sign in  
Chemical Structure| 126411-39-0 Chemical Structure| 126411-39-0

Structure of SR12813
CAS No.: 126411-39-0

Chemical Structure| 126411-39-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

SR-12813 is a pregnane X receptor (PXR) agonist and HMG-CoA reductase inhibitor with an IC50 of 850 nM.

Synonyms: GW 485801

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of SR12813

CAS No. :126411-39-0
Formula : C24H42O7P2
M.W : 504.53
SMILES Code : OC1=C(C(C)(C)C)C=C(C=C(P(OCC)(OCC)=O)P(OCC)(OCC)=O)C=C1C(C)(C)C
Synonyms :
GW 485801
MDL No. :MFCD00888473
InChI Key :YQLJDECYQDRSBI-UHFFFAOYSA-N
Pubchem ID :446313

Safety of SR12813

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HEK293 cells 1 μM 24 h To study the effect of SR12813 on PXR mutants, results showed that the C307A mutant restored SR12813-induced DNA binding. PMC10906221
HepG2 cells 1 μM 24 h To investigate the effect of SR12813 on PXR transactivation capacity, results showed that GSNO significantly decreased SR12813-induced PXR reporter activity. PMC10906221
MCF-7 cells 0.2 µM 12 h Pretreatment led to increased resistance to tamoxifen PMC3392171
MDA-MB-231 cells 0.2 µM 12 h Pretreatment led to increased resistance to Taxol PMC3392171
hCMEC/D3 cells 5 µM 48 or 72 h Used as a positive regulator of P-gp to upregulate P-gp abundance PMC11263236
LS174T-hPXR cells 0.3 μM 7 days To investigate the effect of SR12813 on the proliferation of LS174T-hPXR cells. The results showed that SR12813 significantly promoted cell proliferation, which was inhibited by the PXR antagonist SPA70 PMC7407672
22RV1-hPXR cells 3 μM 16 h To investigate the activation of hPXR by SR12813. The results showed that SR12813 significantly activated hPXR, increasing luciferase expression PMC7407672
HepG2-hPXR cells 3 μM 16 h To investigate the activation of hPXR by SR12813. The results showed that SR12813 significantly activated hPXR, increasing luciferase expression PMC7407672
LS174T-hPXR cells 3 μM 16 h To investigate the activation of hPXR by SR12813. The results showed that SR12813 significantly activated hPXR, increasing luciferase expression PMC7407672
HG5LN GAL4-hPXR cells 3 μM 16 h To investigate the activation of hPXR by SR12813. The results showed that SR12813 significantly activated hPXR, increasing luciferase expression by about 5-fold PMC7407672
THP-1-Blue NFκB cells 10 μM 24 h To evaluate the effect of SR12813 on LPS-induced NFκB signaling, results showed that SR12813 inhibited NFκB signaling. PMC5034705
Caco-2 cells 10 μM 16 h To evaluate the protective effect of SR12813 on TNFα/IFNγ-induced intestinal epithelial barrier dysfunction, results showed that SR12813 pretreatment significantly reduced FITC-dextran flux, indicating barrier protection. PMC5034705

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.98mL

0.40mL

0.20mL

9.91mL

1.98mL

0.99mL

19.82mL

3.96mL

1.98mL

References

 

Historical Records

Categories